Wood Tarver Financial Group, LLC Biogen Inc. Transaction History
Wood Tarver Financial Group, LLC
- $299 Million
- Q4 2024
A detailed history of Wood Tarver Financial Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Wood Tarver Financial Group, LLC holds 44 shares of BIIB stock, worth $6,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44Holding current value
$6,616% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,002Shares Held
131MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.52 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.41 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.19 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.11 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.93MShares$741 Million0.14% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...